Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer function.
about
Exon first nucleotide mutations in splicing: evaluation of in silico prediction toolsPharmacologic correction of dominant-negative GH1 deficiency causing mutations.A molecular basis for variation in clinical severity of isolated growth hormone deficiency type II.Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).
P2860
Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer function.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Isolated growth hormone defici ...... nd splicing enhancer function.
@ast
Isolated growth hormone defici ...... nd splicing enhancer function.
@en
type
label
Isolated growth hormone defici ...... nd splicing enhancer function.
@ast
Isolated growth hormone defici ...... nd splicing enhancer function.
@en
prefLabel
Isolated growth hormone defici ...... nd splicing enhancer function.
@ast
Isolated growth hormone defici ...... nd splicing enhancer function.
@en
P2093
P2860
P1433
P1476
Isolated growth hormone defici ...... nd splicing enhancer function.
@en
P2093
C D Holladay
J A Phillips
J G Patton
R K Cleary
P2860
P304
P356
10.1111/J.1399-0004.2008.01042.X
P577
2008-06-11T00:00:00Z